In The News
NexGen Medical Systems, Inc. (“NexGen” or the “Company”) is a privately held medical device company that has developed a disruptive Venous Thrombo-embolism (“VTE”) technology for the treatment of Deep Vein Thrombosis (“DVT”) and will develop a similar platform for Pulmonary Embolism (“PE”) in the future.
The Company produces the XCOIL® Mechanical Thrombectomy System, a proprietary medical device that ensnares and removes blood clots. Blood clots can cause serious diseases and disorders, including stroke, pulmonary embolism and deep vein thrombosis (leg clots). Blood clots account for more deaths each year than breast cancer, road traffic accidents, and AIDS combined.
The key to better patient outcomes is rapid clot removal. Research suggests that lytic drugs do not always work quickly enough to prevent long-term damage and they also produce negative side effects. The XCOIL® Mechanical Thrombectomy System rapidly restores blood flow by enveloping and removing blood clots in a single, fast and simple procedure without the need for lytic drugs. The NexGen XCOIL® represents the “next step” in the evolution of clot treatment.
12mm XCOIL® Thrombectomy System Animationm
Rapid Restoration of Flow
Atraumatic Retractor; Clot Catching Encapsulator
No Capital Equipment
Fast Procedure Times